Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Hitt

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancers|July 14, 2023
Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia VirusQuinn T Storozynsky, Xuefei Han, Shae Komant, et al.
Plos One|March 18, 2024
Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor modelsBrittany A Umer, Ryan S Noyce, Quinten Kieser, et al.
International Journal of Molecular Sciences|July 18, 2019
RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell LineHuachen Chen, Powel Crosley, Abul K Azad, et al.
International Journal of Molecular Sciences|May 5, 2021
Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In VitroPowel Crosley, Anniina Farkkila, Adrianne L Jenner, et al.
EMBO Molecular Medicine|March 15, 2017
Deletion of <i>F4L</i> (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer modelsKyle G Potts, Chad R Irwin, Nicole A Favis, et al.
Cancer Immunology Research|March 5, 2020
Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast CancerBrittany A Umer, Ryan S Noyce, Brian C Franczak, et al.
Cancer Letters|April 15, 2023
Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma modelQuinn T Storozynsky, Kate C Agopsowicz, Ryan S Noyce, et al.
Heliyon|January 14, 2022
DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative TrialJudith C Hugh, Lacey S J Haddon, John Maringa Githaka, et al.
The Journal of General Virology|February 16, 2006
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirusRaymond H See, Alexander N Zakhartchouk, Martin Petric, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancers|July 14, 2023
Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia VirusQuinn T Storozynsky, Xuefei Han, Shae Komant, et al.
Plos One|March 18, 2024
Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor modelsBrittany A Umer, Ryan S Noyce, Quinten Kieser, et al.
International Journal of Molecular Sciences|July 18, 2019
RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell LineHuachen Chen, Powel Crosley, Abul K Azad, et al.
International Journal of Molecular Sciences|May 5, 2021
Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In VitroPowel Crosley, Anniina Farkkila, Adrianne L Jenner, et al.
EMBO Molecular Medicine|March 15, 2017
Deletion of <i>F4L</i> (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer modelsKyle G Potts, Chad R Irwin, Nicole A Favis, et al.
Cancer Immunology Research|March 5, 2020
Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast CancerBrittany A Umer, Ryan S Noyce, Brian C Franczak, et al.
Cancer Letters|April 15, 2023
Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma modelQuinn T Storozynsky, Kate C Agopsowicz, Ryan S Noyce, et al.
Heliyon|January 14, 2022
DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative TrialJudith C Hugh, Lacey S J Haddon, John Maringa Githaka, et al.
The Journal of General Virology|February 16, 2006
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirusRaymond H See, Alexander N Zakhartchouk, Martin Petric, et al.
Pageof 3